FDA gets $28M to fix infant formula shortage

Bill hr7790-117 ("FDA gets $28M to fix infant formula shortage") is before Congress and has not been decided.

Congress file hr7790-117, before Congress. No action in 1644 days as of 2022-05-18.

What it does

Faster FDA action to restock formula on store shelves The $28 million enables the FDA to expedite inspections, approvals, and supply-chain oversight to restore formula availability during the 2022 shortage and reduce consumer wait times.

The bigger picture

Stronger safeguards against contaminated and counterfeit infant formula FDA can now increase surveillance and enforcement to block fraudulent products from entering the market, protecting infants from health risks that caused the initial supply crisis.

What to watch

Funding addresses immediate crisis but not long-term structural issues The appropriation is temporary (available through September 2023) and focuses on emergency response rather than permanent changes to supply-chain resilience or market concentration among formula manufacturers.

Official summary

Infant Formula Supplemental Appropriations Act, 2022 This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States. Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U.S. market.

How they voted

Yes (152)

No (140)

Did not vote / other (4)

Read the official record for hr7790-117

See everything up for a vote · This week in Congress · See what we have filed with the clerk